NCT07859540 · NOT YET RECRUITING

Negotiation Training for Family Caregivers of People With Alzheimer's Disease

This study tests NegotiAge, an online training program that teaches family caregivers negotiation and communication skills. Researchers will measure whether it lowers caregiver burden, stress, and anxiety. About 200 caregivers will use either NegotiAge or a general educational website. It is a behavioral study with no drug, so no phase applies.

You may qualify if

  • Age 21 years or older
  • Self-identify as a family caregiver or unpaid care partner of a person with Alzheimer's disease, a related dementia, cognitive impairment, or memory loss.
  • Provide at least 2 hours per week of assistance, support, advocacy, healthcare coordination, or decision-making for the care recipient.
  • Able to read, understand, and communicate in English.
  • Able and willing to provide informed consent.
  • Have regular access to an internet-connected computer, tablet, or smartphone and be comfortable using web-based programs and surveys.
  • Willing to be randomized to either the NegotiAge intervention group or the attention-control group and complete all study assessments.

You're excluded if

  • Prior participation in PlanYourLifespan studies (STU00209195 or STU00225351).
  • Prior participation in any NegotiAge study (STU00212921).
  • Younger than 21 years of age.
  • Not currently serving as a family caregiver or unpaid care partner for a person with Alzheimer's disease, a related dementia, cognitive impairment, or memory loss.
  • Unable to provide informed consent.
  • Unable to read, understand, or communicate in English sufficiently to complete study activities.
  • Significant cognitive impairment or another condition that would prevent meaningful participation in study activities.
  • Lack of access to the technology required for participation in the online intervention and study assessments.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-05

View full record on ClinicalTrials.gov

All APOE4 clinical trials